Form 4: Medpace Director Exercises Stock Options
SEC Form 4 Filing
Cornelius P. McCarthy III, a director at Medpace Holdings, Inc., reports the acquisition of 50 shares of common stock through the exercise of restricted stock units on March 31, 2025.
Summary
- On March 31, 2025, Cornelius P. McCarthy III, a director of Medpace Holdings, Inc., exercised restricted stock units, acquiring 50 shares of common stock.
- The transaction was reported on April 2, 2025.
- The director still holds 148 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a standard insider transaction. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on shareholders, as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 2024-11-29 | Reporting Person was granted 198 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. |
| 2025-03-31 | Director exercised restricted stock units, acquiring 50 shares of common stock. |
| 2025-04-02 | Date of report filing. |
Keywords
Medpace Holdings, Director, Stock Options, Form 4, Securities, Ownership, Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.